All episodes

This podcast is published open access in NETH and is fully citeable. You can access the original published podcast article through the NETH website and by using this link: https://link.springer.com/article/10.1007/s40120-023-00506-4  All conflicts of interest can be found online.   Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The material in this podcast...

 In this podcast, the authors summarize and highlight some of the T cell–redirecting bispecific antibodies (BsAb) currently in development for the treatment of relapsed/refractory multiple myeloma with a focus on the data reported at the oral session for BsAb at the American Society of Hematology’s 2022 meeting from clinical phase 1 and 2 studies. The six presentations reported the latest safety and efficacy data for the BsAb: talquetamab, elranatamab, teclistamab, forimtamig, and alnuctamab. This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy...

In this podcast, experts discuss the challenges for implementing vaccine recommendations for individuals with medical conditions at increased risk of developing meningococcal disease. Strategies to increase vaccine coverage are also discussed.     This podcast is published open access in Infectious Diseases and Therapy and is fully citeable. You can access the original published podcast article through the Infectious Diseases and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40121-023-00778-1. All conflicts of interest can be found online.   Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and...

In this plain language podcast, highlights from the European Society for Medical Oncology (ESMO) Congress are discussed for a second year in a row, from the perspective of both a patient advocate and a healthcare professional. Here, the authors discuss the importance of involving patients in the design of clinical trials, as well as strategies to improve dialogue and connections between clinicians, researchers and patients.  This podcast is published open access in Oncology and Therapy and is fully citeable. You can access the original published podcast article through the Oncology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40487-023-00231-w. All conflicts...

This podcast covers topics including the metastatic renal cell carcinoma landscape with a focus on immune-oncology (IO) agents and tyrosine kinase inhibitors, axitinib indication (combination and monotherapy), a summary of efficacy and safety data, dose modification guidelines, and author experience of managing patients with the most common adverse events (AEs) encompassing prior to initiating therapy, patient education, and follow-up.   This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapywebsite and by using this link: https://link.springer.com/article/10.1007/s12325-023-02513-1. All conflicts of interest can be...

In this podcast, Adam Brufsky from the UPMC Hillman Cancer Center, Magee-Women’s Hospital, University of Pittsburgh Medical Center in Pittsburgh, and Christopher Gallagher from the Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC discuss how real-world data in heterogeneous patient populations can complement clinical trial data in informing treatment decision making for patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) metastatic breast cancer. Specifically, their focus is on P-REALITY X, an observational retrospective analysis that was recently published in npj Breast Cancer.  This podcast is published open access in Targeted Oncology and is fully citeable. You can...

In this podcast, Aditya Bardia from the Massachusetts General Hospital, Harvard Medical School in Boston, and Giuseppe Viale from the Department of Pathology and Laboratory Medicine at the European Institute of Oncology in Milan discuss HER2-low breast cancer, including the implications of the recent US FDA and EU approval of trastuzumab deruxtecan (T-DXd) for use in patients with HER2-low breast cancer, the new challenges that this development presents, and ongoing research that will help refine and define HER2-low patient identification. This podcast is published open access in Targeted Oncology and is fully citeable. You can access the original published podcast...

In this podcast article, nurse practitioners discuss multimodal strategies that enable appropriate conversations to meet patients’ needs through the following four techniques: patient-centric language, teach-back, open-ended questions, and active listening and paraphrasing. These techniques are incorporated into example patient–provider conversations to demonstrate their effectiveness in clinical practice. Comprehensive patient conversations and optimizing patient interactions builds a trustworthy foundation for shared decision-making to improve health literacy and outcomes in patients with Multiple Sclerosis.   This podcast is published open access in the journal Neurology and Therapy and is fully citeable. You can access the original published podcast article through the Springerlink...

In this podcast, authors Pamela Kushner and Anne Dalin provide a patient and a clinician discussion on a lived experience of the diagnosis of type 2 diabetes, and the importance of patient education for understanding and managing type 2 diabetes and its complications.   This podcast is published open access in Diabetes Therapy and is fully citeable. You can access the original published podcast article through the Diabetes Therapy website and by using this link: https://link.springer.com/article/10.1007/s13300-023-01378-5. All conflicts of interest can be found online.   Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits...

In this podcast, Thomas John from the Department of Medical Oncology at the Peter MacCallum Cancer Centre in Melbourne, Margarita Majem from the Department of Medical Oncology at the Hospital de la Santa Creu i Sant Pau in Barcelona, Diane Legg, founder of LUNGSTRONG, and Jonathan Goldman from the David Geffen School of Medicine at the University of California in Los Angeles discuss health-related quality of life in resectable EGFR-mutant non-small cell lung cancer. This podcast is published open access in Targeted Oncology and is fully citeable. You can access the original published podcast article through the Targeted Oncology website...